Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase

por Mughal, Tariq I, Schrieber, Andrew
Publicado 2010

Chronic Myeloproliferative Neoplasms: Some Remaining Challenges

por Mughal, Tariq I., Saglio, Giuseppe, Van Etten, Richard A.
Publicado 2018

Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes

por Mughal, Tariq I, Vaddi, Kris, Sarlis, Nicholas J, Verstovsek, Srdan
Publicado 2014

Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?

por Mughal, Tariq I., Deininger, Michael W., Kucine, Nicole, Saglio, Giuseppe, Van Etten, Richard A.
Publicado 2019

Symptom burden and splenomegaly in patients with myelofibrosis in the United States: a retrospective medical record review

por Mitra, Debanjali, Kaye, James A, Piecoro, Lance T, Brown, Jennifer, Reith, Kelly, Mughal, Tariq I, Sarlis, Nicholas J
Publicado 2013

Frequency and Risk Factors of Cyclosporine-Induced Neurotoxicity in Allogeneic Stem Cell Transplant Recipients

por Danish, Asma, Mughal, Sarah I, Zaidi, Uzma, Dildar, Shabnam, Samad, Shafaq, Jamal, Aisha, Sharif, Zainab, Shamsi, Tahir
Publicado 2021

Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021

por Mughal, Tariq I., Psaila, Bethan, DeAngelo, Daniel J., Saglio, Giuseppe, Van Etten, Richard A., Radich, Jerald P.
Publicado 2021

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials

por Galanina, Natalie, Bejar, Rafael, Choi, Michael, Goodman, Aaron, Wieduwilt, Matthew, Mulroney, Carolyn, Kim, Lisa, Yeerna, Huwate, Tamayo, Pablo, Vergilio, Jo-Anne, Mughal, Tariq I., Miller, Vincent, Jamieson, Catriona, Kurzrock, Razelle
Publicado 2018

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

por Pemmaraju, Naveen, Sweet, Kendra L., Stein, Anthony S., Wang, Eunice S., Rizzieri, David A., Vasu, Sumithira, Rosenblat, Todd L., Brooks, Christopher L., Habboubi, Nassir, Mughal, Tariq I., Kantarjian, Hagop, Konopleva, Marina, Lane, Andrew A.
Publicado 2022

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies

por Mughal, Tariq I., Pemmaraju, Naveen, Psaila, Bethan, Radich, Jerald, Bose, Prithviraj, Lion, Thomas, Kiladjian, Jean-Jacques, Rampal, Raajit, Jain, Tania, Verstovsek, Srdnan, Yacoub, Abdulraheem, Cortes, Jorge E., Mesa, Ruben, Saglio, Giuseppe, van Etten, Richard A.
Publicado 2020

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

por Chavan, S S, He, J, Tytarenko, R, Deshpande, S, Patel, P, Bailey, M, Stein, C K, Stephens, O, Weinhold, N, Petty, N, Steward, D, Rasche, L, Bauer, M, Ashby, C, Peterson, E, Ali, S, Ross, J, Miller, V A, Stephens, P, Thanendrarajan, S, Schinke, C, Zangari, M, van Rhee, F, Barlogie, B, Mughal, T I, Davies, F E, Morgan, G J, Walker, B A
Publicado 2017

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer

por Chung, J H, Pavlick, D, Hartmaier, R, Schrock, A B, Young, L, Forcier, B, Ye, P, Levin, M K, Goldberg, M, Burris, H, Gay, L M, Hoffman, A D, Stephens, P J, Frampton, G M, Lipson, D M, Nguyen, D M, Ganesan, S, Park, B H, Vahdat, L T, Leyland-Jones, B, Mughal, T I, Pusztai, L, O’Shaughnessy, J, Miller, V A, Ross, J S, Ali, S M
Publicado 2017